176 related articles for article (PubMed ID: 38556389)
21. Renal medullary carcinoma in a six-year-old boy with sickle cell trait.
Vargas-Gonzalez R; Sotelo-Avila C; Coria AS
Pathol Oncol Res; 2003; 9(3):193-5. PubMed ID: 14530815
[TBL] [Abstract][Full Text] [Related]
22. A Model Linking Sickle Cell Hemoglobinopathies and SMARCB1 Loss in Renal Medullary Carcinoma.
Msaouel P; Tannir NM; Walker CL
Clin Cancer Res; 2018 May; 24(9):2044-2049. PubMed ID: 29440190
[TBL] [Abstract][Full Text] [Related]
23. [Renal Bellini's collecting duct carcinoma: report of a case].
Wang W; Yu GH; Qu GM; Yao WD; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):631. PubMed ID: 21092594
[No Abstract] [Full Text] [Related]
24. A case of renal cell carcinoma unclassified with medullary phenotype without detectable gene deletion.
Tsuzuki S; Kataoka TR; Ito H; Ueshima C; Asai S; Yokoo H; Haga H
Pathol Int; 2019 Dec; 69(12):710-714. PubMed ID: 31617267
[TBL] [Abstract][Full Text] [Related]
25. Balanced Translocations Disrupting SMARCB1 Are Hallmark Recurrent Genetic Alterations in Renal Medullary Carcinomas.
Calderaro J; Masliah-Planchon J; Richer W; Maillot L; Maille P; Mansuy L; Bastien C; de la Taille A; Boussion H; Charpy C; Jourdain A; Bléchet C; Pierron G; Gentien D; Choudat L; Tournigand C; Delattre O; Allory Y; Bourdeaut F
Eur Urol; 2016 Jun; 69(6):1055-61. PubMed ID: 26433572
[TBL] [Abstract][Full Text] [Related]
26. Renal medullary carcinoma: molecular, pathological and clinical evidence for treatment with topoisomerase-inhibiting therapy.
Schaeffer EM; Guzzo TJ; Furge KA; Netto G; Westphal M; Dykema K; Yang X; Zhou M; Teh BT; Pavlovich CP
BJU Int; 2010 Jul; 106(1):62-5. PubMed ID: 20002663
[TBL] [Abstract][Full Text] [Related]
27. Is renal medullary carcinoma the seventh nephropathy in sickle cell disease? A multi-center Nigerian survey.
Anazoeze M; Najibah G; Garba U; Shehu A; Florence F; Abdulaziz H; Marcus I; Oluwaseun A; Theresa N; Obike I; Sunday O; Ifeoma E; Anthony I; Barth C; Chide O; Joseph O; Malachy I; Kaladada K; Uche A; Kingsley A; Charles N; Angela U; Augustin D; Chikwudi A; Alozie E; Uchenna O; Caroline O; Obineche A; Iheanyi O
Afr Health Sci; 2016 Jun; 16(2):490-6. PubMed ID: 27605964
[TBL] [Abstract][Full Text] [Related]
28. Discovery of a renal medullary carcinoma in an adolescent male with sickle cell trait by Tc-99m methylene disphosponate bone scintigraphy.
Brown JM; Berkey BD; Brooks JA
Clin Nucl Med; 2008 Dec; 33(12):896-900. PubMed ID: 19033803
[TBL] [Abstract][Full Text] [Related]
29. Renal medullary carcinomas: histopathologic phenotype associated with diverse genotypes.
Gatalica Z; Lilleberg SL; Monzon FA; Koul MS; Bridge JA; Knezetic J; Legendre B; Sharma P; McCue PA
Hum Pathol; 2011 Dec; 42(12):1979-88. PubMed ID: 21733559
[TBL] [Abstract][Full Text] [Related]
30. SMARCB1 regulates the hypoxic stress response in sickle cell trait.
Soeung M; Perelli L; Chen Z; Dondossola E; Ho IL; Carbone F; Zhang L; Khan H; Le CN; Zhu C; Peoples MD; Feng N; Jiang S; Zacharias NM; Minelli R; Shapiro DD; Deem AK; Gao S; Cheng EH; Lucchetti D; Walker CL; Carugo A; Giuliani V; Heffernan TP; Viale A; Tannir NM; Draetta GF; Msaouel P; Genovese G
Proc Natl Acad Sci U S A; 2023 May; 120(21):e2209639120. PubMed ID: 37186844
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
Msaouel P; Malouf GG; Su X; Yao H; Tripathi DN; Soeung M; Gao J; Rao P; Coarfa C; Creighton CJ; Bertocchio JP; Kunnimalaiyaan S; Multani AS; Blando J; He R; Shapiro DD; Perelli L; Srinivasan S; Carbone F; Pilié PG; Karki M; Seervai RNH; Vokshi BH; Lopez-Terrada D; Cheng EH; Tang X; Lu W; Wistuba II; Thompson TC; Davidson I; Giuliani V; Schlacher K; Carugo A; Heffernan TP; Sharma P; Karam JA; Wood CG; Walker CL; Genovese G; Tannir NM
Cancer Cell; 2020 May; 37(5):720-734.e13. PubMed ID: 32359397
[TBL] [Abstract][Full Text] [Related]
32. Renal medullary carcinomas depend upon
Hong AL; Tseng YY; Wala JA; Kim WJ; Kynnap BD; Doshi MB; Kugener G; Sandoval GJ; Howard TP; Li J; Yang X; Tillgren M; Ghandi M; Sayeed A; Deasy R; Ward A; McSteen B; Labella KM; Keskula P; Tracy A; Connor C; Clinton CM; Church AJ; Crompton BD; Janeway KA; Van Hare B; Sandak D; Gjoerup O; Bandopadhayay P; Clemons PA; Schreiber SL; Root DE; Gokhale PC; Chi SN; Mullen EA; Roberts CW; Kadoch C; Beroukhim R; Ligon KL; Boehm JS; Hahn WC
Elife; 2019 Mar; 8():. PubMed ID: 30860482
[TBL] [Abstract][Full Text] [Related]
33. Renal medullary carcinoma and sickle cell trait: A systematic review.
Alvarez O; Rodriguez MM; Jordan L; Sarnaik S
Pediatr Blood Cancer; 2015 Oct; 62(10):1694-9. PubMed ID: 26053587
[TBL] [Abstract][Full Text] [Related]
34. Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
Shah AY; Karam JA; Malouf GG; Rao P; Lim ZD; Jonasch E; Xiao L; Gao J; Vaishampayan UN; Heng DY; Plimack ER; Guancial EA; Fung C; Lowas SR; Tamboli P; Sircar K; Matin SF; Kimryn Rathmell W; Wood CG; Tannir NM
BJU Int; 2017 Dec; 120(6):782-792. PubMed ID: 27860149
[TBL] [Abstract][Full Text] [Related]
35. [SMARCB1(INI1)-deficient renal cell carcinoma: medullary and beyond : Evolving concepts].
Agaimy A; Hartmann A
Pathologe; 2021 Nov; 42(6):571-577. PubMed ID: 34609565
[TBL] [Abstract][Full Text] [Related]
36. Renal medullary carcinoma and ABL gene amplification.
Simpson L; He X; Pins M; Huang X; Campbell SC; Yang XJ; Perlman EJ; Bergan RC
J Urol; 2005 Jun; 173(6):1883-8. PubMed ID: 15879768
[TBL] [Abstract][Full Text] [Related]
37. Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series.
Ryan A; Tawagi K; VanderVeen N; Matrana M; Vasquez R
Clin Genitourin Cancer; 2021 Dec; 19(6):e395-e400. PubMed ID: 34565708
[TBL] [Abstract][Full Text] [Related]
38. The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group.
Franzese C; Marvaso G; Francolini G; Borghetti P; Trodella LE; Sepulcri M; Matrone F; Nicosia L; Timon G; Ognibene L; Vinciguerra A; Alongi F; Bortolus R; Corti L; Ramella S; Magrini SM; Livi L; Jereczek-Fossa BA; Scorsetti M; Arcangeli S
Clin Exp Metastasis; 2021 Dec; 38(6):527-537. PubMed ID: 34748125
[TBL] [Abstract][Full Text] [Related]
39. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases.
Jia L; Carlo MI; Khan H; Nanjangud GJ; Rana S; Cimera R; Zhang Y; Hakimi AA; Verma AK; Al-Ahmadie HA; Fine SW; Gopalan A; Sirintrapun SJ; Tickoo SK; Reuter VE; Gartrell BA; Chen YB
Mod Pathol; 2019 Sep; 32(9):1329-1343. PubMed ID: 30980040
[TBL] [Abstract][Full Text] [Related]
40. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma.
Pirich LM; Chou P; Walterhouse DO
J Pediatr Hematol Oncol; 1999; 21(1):67-9. PubMed ID: 10029817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
